http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006008009-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e04826845acea4cc4cdeafc4c2b1e313
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0ef5c3365be7092a20772a4b3afd553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d41ec0461f1dcf5db85678f027758111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d1596f64ec0b2dac5334b2cf05b88bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d37eb461745b8d691065349d29825942
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
filingDate 2005-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fa644991af26b2ab32246087c7e7d0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fdf74c1bcb0c1a90b3bafcf1461d4cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_065163eea113d79135e234e55d45e2a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2310f9aff201276f5c535b04d852157d
publicationDate 2006-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006008009-A3
titleOfInvention Diagnostics and therapeutics for diseases associated with leucine-rich repeat-containing gpcr 6 (lgr6)
abstract The invention provides a human LGR6 which is associated with the cardiovascular disorders, endocrine system and hormone disorders, metabolic diseases, hematological disorders, respiratory diseases, inflammatory diseases, neurological disorders, reproduction disorders, cancer disorders and urological disorders. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular disorders, endocrine system and hormone disorders, metabolic diseases, hematological disorders, respiratory diseases, inflammatory diseases, neurological disorders, reproduction disorders, cancer disorders and urological disorders. The invention also features compounds which bind to and/or activate or inhibit the activity of LGR6 as well as pharmaceutical compositions comprising such compounds.
priorityDate 2004-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03025148-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004040000-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004058818-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986

Total number of triples: 25.